Microba Life Sciences Share Price and Company Fundamentals
Last traded: Today at 12:57 AM
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates in two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore that provides a range of diagnostics solution under the Co-Biome brand; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, and inflammatory bowel and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
Key Metrics
PE ratio
-
PB ratio
1.38
Dividend yield
-
Beta
2.42
Market cap
$52.98M
Enterprise value
$35.65M
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Website | https://microba.com |
| Mailing address | 324 Queen Street Level 10 Brisbane QLD 4000 Australia |
| Phone / Fax | 61 13 0097 4621 / 61 13 0097 4621 |
Dividends
More: Microba Life Sciences Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Microba Life Sciences paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MAP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Microba Life Sciences.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Luke Reid | Chief Executive Officer | ||
| Prof. Gene Tyson | Co-Founder & Non-Executive Director | ||
| Mr. James Heath | CFO & Company Secretary | ||
| Prof. Philip Hugenholtz | Co-Founder & Chair of Scientific Advisory Board | ||
| Dr. David Wood | Chief Technology Officer | ||
| Prof. Lutz Krause | Chief Scientific Officer | ||
| Dr. Nicola Angel | Head of Laboratory Operations & Laboratory Director | ||
| Keith Byrne | Head of Test Operations | ||
| Eric Davies | Chief Revenue Officer | ||
| Alaster Stockwell-Jones | Managing Director of UK |
Profitability and management effectiveness
Profit margin
-95.34%
Operating margin
-179.34%
Return on assets
-28.99%
Return on equity
-40.54%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Microba Life Sciences is 52.98M and its enterprise value is 35.65M. The enterprise value to revenue ratio of MAP is 2.27. The enterprise value to EBITDA ratio of MAP is -1.59.
The MAP's stocks Beta value is 2.42 making it 142% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Microba Life Sciences (MAP)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Microba Life Sciences (ASX:MAP) Frequently Asked Questions
1. What is Microba Life Sciences's Stock Symbol?
Microba Life Sciences trades on ASX under the ticker symbol "MAP".
2. What is Microba Life Sciences's stock price today?
One share of MAP stock can currently be purchased for approximately $0.087.
3. How can I contact Microba Life Sciences?
Microba Life Sciences's mailing address is 324 Queen Street Level 10 Brisbane QLD 4000 Australia. The company can be reached via phone at 61 13 0097 4621.
4. What is Microba Life Sciences's official website?
The official website of Microba Life Sciences is https://microba.com.